Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01638481 · ClinicalTrials.gov registry record
Chronology of Occult and Gross Coagulopathy in Burn Patients
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 158
- Enrollment target
NCT01638481: Completed study, sponsored by Medstar Health Research Institute.
NCT01638481 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 158 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01638481 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
The purpose of the study is to identify the inflammatory and coagulation pathways and mechanisms that are activated immediately following burn injury, and how they affect outcomes in terms of organ failure and death. This study also addresses the limitation of current tests (PT, PTT, and platelet counts) employed to identify coagulation disturbances in severely injured patients both in a comprehensive and rapid manner.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2012-07 |
| Est. Completion | 2021-06 |
What the finished NCT01638481 record still lists
NCT01638481 is an observational study that tracks outcomes without assigning an intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01638481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01638481 about?
NCT01638481 is a clinical study titled "Chronology of Occult and Gross Coagulopathy in Burn Patients". The purpose of the study is to identify the inflammatory and coagulation pathways and mechanisms that are activated immediately following burn injury, and how they affect outcomes in terms of organ failure and death. This study also addresses the limitation of current tests (PT, PTT, and platelet co...
What is the current status of trial NCT01638481?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2012-07. Estimated completion is 2021-06.
Who is sponsoring clinical trial NCT01638481?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia